Skip to main content

WPI 3699 (Levetiracetam Extended Release 750 mg)

Pill with imprint WPI 3699 is White, Round and has been identified as Levetiracetam Extended Release 750 mg. It is supplied by Watson Laboratories, Inc.

Levetiracetam is used in the treatment of seizures; epilepsy and belongs to the drug class pyrrolidine anticonvulsants. Risk cannot be ruled out during pregnancy. Levetiracetam 750 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for WPI 3699

Levetiracetam extended release 750 mg WPI 3699

Levetiracetam Extended Release

Imprint
WPI 3699
Strength
750 mg
Color
White
Shape
Round
Availability
Prescription only
Drug Class
Pyrrolidine anticonvulsants
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Watson Laboratories, Inc.
National Drug Code (NDC)
00591-3699 (Discontinued)
Inactive Ingredients
cellulose acetate, silicon dioxide, soya lecithin, magnesium stearate, polyethylene glycol 400, polyethylene glycol 3350, sodium lauryl sulfate, magnesium silicate, titanium dioxide, ferrosoferric oxide, propylene glycol

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.